The present proof-of-concept study aimed to investigate the potential and dynamics of quantitative SEPT9 and SHOX2 methylation in PCa tissue and ccfDNA during prostate biopsy as a diagnostic tool. This evidence concerns the gene SEPTIN9 and posterior cortical atrophy.